Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 53, Issue 12 (Nov 2015)

Issues

The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid

Jamie Toombs
  • Corresponding author
  • Institute of Neurology, Department of Molecular Neuroscience, University College London, London, UK
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ross W. Paterson / Jennifer M. NicholasORCID iD: http://orcid.org/0000-0001-6023-0391 / Axel Petzold
  • Institute of Neurology, Department of Molecular Neuroscience, University College London, London, UK
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jonathan M. Schott / Henrik Zetterberg
  • Institute of Neurology, Department of Molecular Neuroscience, University College London, London, UK
  • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2015-06-23 | DOI: https://doi.org/10.1515/cclm-2015-0414

References

  • 1.

    Moulder KL, Snider BJ, Mills SL, Buckles VD, Santacruz AM, Bateman RJ, et al. Dominantly Inherited Alzheimer Network: facilitating research and clinical trials. Alzheimers Res Ther 2013;5:48.Web of SciencePubMedCrossrefGoogle Scholar

  • 2.

    U.S. Food and Drugs Administration. Guidance for industry bioanalytical method validation. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm368107.pdf. Accessed 27 October, 2014.

  • 3.

    Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK. Longitudinal changes of CSF biomarkers in Alzheimer’s disease. J Alzheimers Dis 2011;25:583–94.PubMedGoogle Scholar

  • 4.

    Toombs J, Paterson RW, Lunn MP, Nicholas JM, Fox NC, Chapman MD, et al. Identification of an important potential confound in CSF AD studies: aliquot volume. Clin Chem Lab Med 2013;51:2311–7.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 5.

    Toombs J, Paterson RW, Schott JM, Zetterberg H. Amyloid-beta 42 adsorption following serial tube transfer. Alzheimers Res Ther 2014;6:5.CrossrefWeb of ScienceGoogle Scholar

  • 6.

    Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010;6:131–44.CrossrefPubMedGoogle Scholar

  • 7.

    ISO 5725-2, Accuracy (trueness and precision) of measurement methods and results – Part 2: Basic method for the determination of repeatability and reproducibility of a standard measurement method. 1994.Google Scholar

  • 8.

    R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2012. Available from: http://www.R-project.org/

  • 9.

    Pinheiro J, Bates D, DebRoy S, Sarkar D, R Development Core Team. nlme: linear and nonlinear mixed effects models. R package version 3.1-108. 2013.Google Scholar

  • 10.

    Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med 2014;370:322–33.Web of ScienceCrossrefGoogle Scholar

About the article

Corresponding author: Jamie Toombs, Institute of Neurology, Department of Molecular Neuroscience, University College London, London, UK, Phone: + 44 20 34483553, E-mail:


Received: 2015-04-30

Accepted: 2015-05-27

Published Online: 2015-06-23

Published in Print: 2015-11-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2015-0414.

Export Citation

©2015 by De Gruyter. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Hugo Marcel Johan Vanderstichele, Shorena Janelidze, Leentje Demeyer, Els Coart, Erik Stoops, Victor Herbst, Kimberley Mauroo, Britta Brix, Oskar Hansson, and Daniela Galimberti
Journal of Alzheimer's Disease, 2016, Volume 53, Number 3, Page 1121

Comments (0)

Please log in or register to comment.
Log in